Dendreon Corp fka DNDNQ

[iwfal]

When discussing the P-11 trial with Monique several months ago, she told me that the P-11 end point was Time to PSA doubling, which of course is grossly wrong.

One of the reasons I do not work too hard to get data from a IR. Until I hear an moderately authoritative explanation(!) of why Provost's CD54 paper talks of only 104 measurements for P-11 in Jan of 06 I will not fully trust that Jun 05 was >170 patients randomized.